1-(3-甲基环己基)甲胺 | 34147-55-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-(3-甲基环己基)甲胺
• 英文名称: (3-methylcyclohexyl)methanamine
• 英文别名: 1-Aminomethyl-3-methyl-cyclohexan；C-(3-methyl-cyclohexyl)-methylamine；1¹-Amino-1.3-dimethyl-cyclohexan；3-Methyl-hexahydrobenzylamin；1-Methyl-3-aminomethyl-cyclohexan
• CAS: 34147-55-2
• 化学式: C₈H₁₇N
• 分子量: 127.23
• InChiKey: AVBFYDXLBKBKNT-UHFFFAOYSA-N

物化性质

• 沸点：
  114-116 °C(Press: 80 Torr)
• 密度：
  0.841±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 乙醇 、 sodium 作用下， 生成 1-(3-甲基环己基)甲胺
  参考文献：
  名称：

  Grignard; Bellet; Courtot, Annales de Chimie (Cachan, France), 1919, vol. <9> 12, p. 382

  摘要：

  DOI：

文献信息

• [EN] PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS<br/>[FR] DÉRIVÉS PYRROLIDINE ET LEUR UTILISATION EN TANT QUE MODULATEURS DE LA VOIE DU COMPLÉMENT
  申请人：NOVARTIS AG

  公开号：WO2014002054A1

  公开（公告）日：2014-01-03

  The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as complement pathway modulators for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种化合物(I)的方法，用于制造该发明的化合物，并将其用作眼部疾病治疗的补体途径调节剂。本发明还提供了一种药理活性剂的组合和制药组合物。
• One-pot reductive amination of carboxylic acids: a sustainable method for primary amine synthesis
  作者：Robin Coeck、Dirk E. De Vos

  DOI：10.1039/d0gc01441a

  日期：——

  carboxylic acids is a very green, efficient and sustainable method for the production of (bio-based) amines. However, with current technology, this reaction requires two to three reaction steps. Here, we report the first (heterogeneous) catalytic system for the one-pot reductive amination of carboxylic acids to amines, with solely H2 and NH3 as the reactants. This reaction can be performed with relatively cheap

  羧酸的还原胺化是一种非常绿色，高效和可持续的生产（生物基）胺的方法。但是，使用当前技术，该反应需要两到三个反应步骤。在这里，我们报道了第一个（非均相）催化体系，用于仅用H 2和NH 3作反应物将羧酸单胺还原胺化。该反应可以使用相对便宜的钌-钨双金属催化剂在绿色和良性溶剂环戊基甲基醚（CPME）中进行。在高转化率下，伯胺的选择性可达99％。另外，该催化剂是可回收的并且对常见杂质如水和阳离子（例如羧酸钠）具有耐受性。
• [EN] ORAL COMPLEMENT FACTOR D INHIBITORS<br/>[FR] INHIBITEURS DE FACTEUR D DU COMPLÉMENT ORAL
  申请人：BIOCRYST PHARM INC

  公开号：WO2021072156A1

  公开（公告）日：2021-04-15

  Disclosed are compounds of formula (I)-(IV), and pharmaceutically acceptable salts thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity.

  揭示了式(I)-(IV)的化合物及其药用可接受的盐，这些化合物是补体系统的抑制剂。还提供了包含这种化合物的药物组合物，以及使用这些化合物和组合物治疗或预防由异常补体系统活动特征的疾病或状况的方法。
• MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES
  申请人：Vielhaber Gabriele

  公开号：US20130129646A1

  公开（公告）日：2013-05-23

  The present invention relates to the cosmetic, dermatological or pharmaceutical (therapeutic) use of compounds of formula (I) or a cosmetically acceptable salt of a compound of formula (I) or a mixture containing two or more of these compounds or the salts thereof wherein R 1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R 2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R 1 and R 2 are covalently bonded to one another, preferably so that a 3 to 8 membered ring is formed, for the lightening of skin and/or hair. The invention further relates to compositions and cosmetic, dermatological or pharmaceutical preparations (compositions) comprising one or more compounds of formula (I) suitable for lightening human skin and/or hair and corresponding methods. The invention further relates to compounds of formula (I) as a drug, their use for the preparation of a pharmaceutical composition for lightening human skin and/or hair and to certain novel compounds of formula (I).

  本发明涉及化妆品、皮肤科或药用（治疗）用途的化合物的使用，其化学式为（I）或者化学式（I）的化妆品可接受的盐，或者含有两种或更多这些化合物或其盐的混合物，其中R1代表氢或具有1至14个碳原子的有机基，R2代表具有1至14个碳原子的有机基，可选地R1和R2彼此共价结合，最好形成3至8成员环，用于美白皮肤和/或头发。该发明还涉及包含一种或多种化学式（I）化合物的组合物和适用于美白人类皮肤和/或头发的化妆品、皮肤科或药用制剂（组合物）及相应的方法。该发明还涉及化学式（I）化合物作为药物，其用于制备用于美白人类皮肤和/或头发的药用组合物以及某些新的化学式（I）化合物。
• [EN] CONDURITOL AZIRIDINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS D'AZIRIDINE DE CONDURITOL ET LEURS UTILISATIONS
  申请人：UNIV SASKATCHEWAN

  公开号：WO2019075574A1

  公开（公告）日：2019-04-25

  The present application relates to conduritol aziridines of Formula (I), and uses thereof, for example, of 18F-labelled derivatives thereof in positron-emission tomography (PET) imaging of β-glucocerebrosidase activity.

  本申请涉及式(I)的康杜糖异丙环烷以及其用途，例如18F标记衍生物在β-葡萄糖鞘脂酶活性的正电子发射断层扫描（PET）成像中的应用。